Leukemia drug combo is encouraging in early Phase I clinical trial
SAN DIEGO, CA (December 5, 2016)--Researchers from Columbia University Medical Center and NewYork-Presbyterian reported that 8 out of 12 patients with relapsed and/or chemotherapy refractory...